-
Scipher Medicine Appoints Dr. Michael Elliott to its Science Advisory Board -
America’s Choice Provider Network Partners with Scipher Medicine to Improve Patient Outcomes and Lower Costs for Rheumatoid Arthritis Care -
Scipher Medicine® Appoints Sam Asgarian, M.D., MBA, Chief Medical Officer -
GNS Healthcare and Scipher Medicine® Collaborate to Develop World’s First in silico Patient for Rheumatoid Arthritis -
TARA Biosystems Partners with Scipher Medicine® -
Trellis Rx Furthers Commitment to Advancing the Specialty Pharmacy Practice and Patient Outcomes with Integration of Scipher Medicine® PrismRA® Precision-Medicine Technology into Clinical Pathways -
Scipher Medicine Strengthens Leadership Team with Appointment of Sam A Davis, JD as General Counsel -
Scipher Medicine Welcomes John Strumbos as Chief Financial Officer -
Scipher Medicine Welcomes Chip Parkinson as Chief Commercial Officer of its Diagnostics Business -
Ventegra Partners with Scipher Medicine For Patient-Centric Approach To Improve Outcomes and Lower Costs for Rheumatoid Arthritis Care -
Scipher Medicine Increases Patient Access for PrismRA® by Expanding Intended Use in Autoimmune Patients -
Scipher Medicine Announces PrismRA® Met Primary and Secondary Endpoints in Prospective Observational Study Predicting Inadequate Response to World’s Largest-Selling Drug Class, TNFi -
Scipher Medicine Presents New Data at the European League Against Rheumatism (EULAR) 2021 Further Validating PrismRA® Test -
Scipher Medicine and Leading Medical Researchers in Network and Data Science Compress Time to Identify Covid-19 Treatments from Years to Months -
Scipher Applies SpectraTM Platform to Discover Drugs Targeting Autoimmune Patients Refractory to Existing Therapies